chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Itchy site of injection; Red site of injection; Skin temperature at site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Skin temperature at site of injection), VACCINATION SITE PRURITUS (Itchy site of injection) and VACCINATION SITE ERYTHEMA (Red site of injection) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013LZ0A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Skin temperature at site of injection). On 07-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy site of injection) and VACCINATION SITE ERYTHEMA (Red site of injection). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ITCH) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Skin temperature at site of injection), VACCINATION SITE PRURITUS (Itchy site of injection) and VACCINATION SITE ERYTHEMA (Red site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication were not reported by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: 27 weeks pregnant; received both doses of Moderna COVID-19 vaccine; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (27 weeks pregnant; received both doses of Moderna COVID-19 vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (27 weeks pregnant; received both doses of Moderna COVID-19 vaccine). At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (27 weeks pregnant; received both doses of Moderna COVID-19 vaccine) had resolved.            No concomitant medication information was provided by the reporter. No treatment information was provided by the reporter.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: itchiness at injection site; rash at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchiness at injection site) and VACCINATION SITE RASH (rash at injection site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included GABAPENTIN, ZOLPIDEM TARTRATE (AMBIEN), VITAMINS NOS and 12 VITAMINS FOR INJECTION for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (itchiness at injection site) and VACCINATION SITE RASH (rash at injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at a dose of 1 dosage form and HYDROCORTISONE ongoing since an unknown date at an unspecified dose and frequency. On 30-Jan-2021, VACCINATION SITE PRURITUS (itchiness at injection site) and VACCINATION SITE RASH (rash at injection site) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Itchy; Rash at the site; Red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE RASH (Rash at the site) and VACCINATION SITE ERYTHEMA (Red) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE RASH (Rash at the site) and VACCINATION SITE ERYTHEMA (Red). The patient was treated with PETROLATUM (CERAVE HEALING OINTMENT) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE RASH (Rash at the site) and VACCINATION SITE ERYTHEMA (Red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication details were not reported by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: Feeling Very Sick; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Feeling Very Sick) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MALAISE (Feeling Very Sick). At the time of the report, MALAISE (Feeling Very Sick) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Ephelides, Vaccination site induration, Vaccination site pain, Vaccination site warmth
Clinical narrative: Arm was hurting; Arm was hot; Developed a "freckle" that got bigger but now gone; Arm still has a little internal bump; A spontaneous report  was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events arm was hurting at injection site, developed a freckle that got bigger but now gone, arm was hot at injection site, arm still has a little internal bump.  The patient's medical history was not provided. Concomitant medications reported were Thyroxin, High blood pressure medication for drug use for unknown indication.  On 29 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot number: 030L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event(s) Arm was hurting at injection site, Developed a freckle that got bigger but now gone, Arm was hot at injection site, Arm still has a little internal bump.  Treatment details included Acetaminophen.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), arm was hurting at injection site, developed a freckle that got bigger but now gone, arm was hot at injection site, arm still has a little internal bump was unknown.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Gait inability, Pain, Pain in extremity, Pharyngeal swelling
Clinical narrative: both arms and both legs were extremely achy; hurt all inside; was so sore could hardly walk; difficult to breathe; felt like throat was swelling; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (both arms and both legs were extremely achy), PAIN (hurt all inside), GAIT INABILITY (was so sore could hardly walk), DYSPNOEA (difficult to breathe) and PHARYNGEAL SWELLING (felt like throat was swelling) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013m20a) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced PAIN IN EXTREMITY (both arms and both legs were extremely achy), PAIN (hurt all inside), GAIT INABILITY (was so sore could hardly walk), DYSPNOEA (difficult to breathe) and PHARYNGEAL SWELLING (felt like throat was swelling). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 500 mg. At the time of the report, PAIN IN EXTREMITY (both arms and both legs were extremely achy), PAIN (hurt all inside), GAIT INABILITY (was so sore could hardly walk), DYSPNOEA (difficult to breathe) and PHARYNGEAL SWELLING (felt like throat was swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication were not reported by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications and treatment medications were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 24-Feb-2021: Internal review on 20 Jul 2021 resulted in the update of event verbatim and outcome, pregnancy details (birth type and fetal outcome).
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Rash macular, Vaccination site reaction
Clinical narrative: 3 days after I noticed on opposite arm of vaccine looks like either spot of shingles doesn't itch, doesn't hurt; its little bit lower than where you get the vaccine but on the other arm; raised spot towards the back of the arm; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (3 days after I noticed on opposite arm of vaccine looks like either spot of shingles doesn't itch, doesn't hurt), VACCINATION SITE REACTION (its little bit lower than where you get the vaccine but on the other arm) and RASH MACULAR (raised spot towards the back of the arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced HERPES ZOSTER (3 days after I noticed on opposite arm of vaccine looks like either spot of shingles doesn't itch, doesn't hurt), VACCINATION SITE REACTION (its little bit lower than where you get the vaccine but on the other arm) and RASH MACULAR (raised spot towards the back of the arm). At the time of the report, HERPES ZOSTER (3 days after I noticed on opposite arm of vaccine looks like either spot of shingles doesn't itch, doesn't hurt), VACCINATION SITE REACTION (its little bit lower than where you get the vaccine but on the other arm) and RASH MACULAR (raised spot towards the back of the arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity, Pruritus, Vaccination site erythema
Clinical narrative: Arm sore; Arm was very itching; Fatigue; Redness at the injection site in an area about 4 inches in the shoulder; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm sore), PRURITUS (Arm was very itching), VACCINATION SITE ERYTHEMA (Redness at the injection site in an area about 4 inches in the shoulder) and FATIGUE (Fatigue) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness at the injection site in an area about 4 inches in the shoulder). On 21-Jan-2021, the patient experienced FATIGUE (Fatigue). On 30-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm sore) and PRURITUS (Arm was very itching). On 06-Feb-2021, PRURITUS (Arm was very itching) had resolved. At the time of the report, PAIN IN EXTREMITY (Arm sore), VACCINATION SITE ERYTHEMA (Redness at the injection site in an area about 4 inches in the shoulder) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication details were not reported by the reporter. Treatment included bandage over the zone to avoid touching it.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: big red spot; swollen; itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (big red spot), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE PRURITUS (itchy) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031m20a) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (big red spot), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE PRURITUS (itchy). At the time of the report, VACCINATION SITE ERYTHEMA (big red spot), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE PRURITUS (itchy) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  Treatment included triamcinolone acetonide cream   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: TCR received
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Positive test after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Positive test after 1st dose) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced COVID-19 (Positive test after 1st dose). At the time of the report, COVID-19 (Positive test after 1st dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Feb-2021, COVID-19: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain, Pain in extremity
Clinical narrative: Leg pain; Fatigue; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Leg pain), FATIGUE (Fatigue) and PAIN (Body aches) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     The patient's past medical history included Myasthenia gravis.    On 20-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 23-Feb-2021, the patient experienced PAIN IN EXTREMITY (Leg pain), FATIGUE (Fatigue) and PAIN (Body aches). At the time of the report, PAIN IN EXTREMITY (Leg pain), FATIGUE (Fatigue) and PAIN (Body aches) outcome was unknown. Not Provided          No concomitant medication was provided.  No treatment details were provided.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pain, Pyrexia
Clinical narrative: Soreness; Body aches; Fever of 100.7; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Soreness), PAIN (Body aches), PYREXIA (Fever of 100.7) and CHILLS (Chills) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypothyroidism since 01-Jul-1977, Sleep apnea (Recent change in status of chronic condition took place. On 08-Apr-2021 a sleep study found that the patient have Central apnea.) since 13-May-2009 and Drug hypersensitivity (Allergy to Hydrocodone). Concomitant products included ATORVASTATIN from 2000 to an unknown date for High cholesterol, LEVOTHYROXINE SODIUM (SYNTHROID) from 1977 to an unknown date for Hypothyroidism, VITAMIN D [VITAMIN D NOS], VITAMIN C [ASCORBIC ACID] and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (Soreness), PAIN (Body aches), PYREXIA (Fever of 100.7) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) for Ache, at an unspecified dose and frequency. At the time of the report, PAIN (Soreness), PAIN (Body aches), PYREXIA (Fever of 100.7) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.7 (High) increased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-240860 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Follow up received: Patient demographics, medical history, concomitant medication added; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Vaccination site pain
Clinical narrative: injection site was hurt / could not reach up with the left arm; chills; muscle aches all over; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (injection site was hurt / could not reach up with the left arm), CHILLS (chills) and MYALGIA (muscle aches all over) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE PAIN (injection site was hurt / could not reach up with the left arm), CHILLS (chills) and MYALGIA (muscle aches all over). On 24-Jan-2021, VACCINATION SITE PAIN (injection site was hurt / could not reach up with the left arm), CHILLS (chills) and MYALGIA (muscle aches all over) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, COVID-19, Feeling cold, Myalgia, Sleep disorder
Clinical narrative: COVID-19; coldness; sleep disorder; injection site pain; Myalgia; joint ache; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19), FEELING COLD (coldness), SLEEP DISORDER (sleep disorder), VACCINATION SITE PAIN (injection site pain) and MYALGIA (Myalgia) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy NOS.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced COVID-19 (COVID-19), FEELING COLD (coldness), SLEEP DISORDER (sleep disorder), VACCINATION SITE PAIN (injection site pain), MYALGIA (Myalgia) and ARTHRALGIA (joint ache). At the time of the report, COVID-19 (COVID-19), FEELING COLD (coldness), SLEEP DISORDER (sleep disorder), VACCINATION SITE PAIN (injection site pain), MYALGIA (Myalgia) and ARTHRALGIA (joint ache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: COVID-19; coldness; sleep disorder; injection site pain; Myalgia; joint ache; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19), FEELING COLD (coldness), SLEEP DISORDER (sleep disorder), VACCINATION SITE PAIN (injection site pain) and MYALGIA (Myalgia) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy NOS.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced COVID-19 (COVID-19), FEELING COLD (coldness), SLEEP DISORDER (sleep disorder), VACCINATION SITE PAIN (injection site pain), MYALGIA (Myalgia) and ARTHRALGIA (joint ache). At the time of the report, COVID-19 (COVID-19), FEELING COLD (coldness), SLEEP DISORDER (sleep disorder), VACCINATION SITE PAIN (injection site pain), MYALGIA (Myalgia) and ARTHRALGIA (joint ache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Disorientation, Headache, Influenza like illness, Pyrexia
Clinical narrative: disorientation; Flu like symtoms; Headache; chills; high fever; This spontaneous case was reported by a consumer and describes the occurrence of DISORIENTATION (disorientation), INFLUENZA LIKE ILLNESS (Flu like symtoms), HEADACHE (Headache), CHILLS (chills) and PYREXIA (high fever) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included PARACETAMOL (TYLENOL) and ATORVASTATIN for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DISORIENTATION (disorientation), INFLUENZA LIKE ILLNESS (Flu like symtoms), HEADACHE (Headache), CHILLS (chills) and PYREXIA (high fever). At the time of the report, DISORIENTATION (disorientation), INFLUENZA LIKE ILLNESS (Flu like symtoms), HEADACHE (Headache), CHILLS (chills) and PYREXIA (high fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details was not reported by the reporter.   Reporter did not allow further contact
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: itching of injection site; red mark on injectionsite; headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itching of injection site), VACCINATION SITE ERYTHEMA (red mark on injectionsite) and HEADACHE (headache) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itching of injection site), VACCINATION SITE ERYTHEMA (red mark on injectionsite) and HEADACHE (headache). At the time of the report, VACCINATION SITE PRURITUS (itching of injection site), VACCINATION SITE ERYTHEMA (red mark on injectionsite) and HEADACHE (headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details was not reported by the reporter.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: It did itch; 2 weeks later developed a round circle rash   ,1/3 of a dime around; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (It did itch) and VACCINATION SITE RASH (2 weeks later developed a round circle rash   ,1/3 of a dime around) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L2OA) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure. Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (It did itch) and VACCINATION SITE RASH (2 weeks later developed a round circle rash   ,1/3 of a dime around). The patient was treated with CORTISONE ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (It did itch) and VACCINATION SITE RASH (2 weeks later developed a round circle rash   ,1/3 of a dime around) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications details was included generic blood pressure medicine.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Induration, Pain, Pruritus, Vaccination site erythema, Vaccination site pain
Clinical narrative: Traveling down to the elbow; Itchy; Felt hard; Injection site  red; Injection site was sore; felt like it was burning; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Traveling down to the elbow), PRURITUS (Itchy), INDURATION (Felt hard), VACCINATION SITE ERYTHEMA (Injection site  red) and VACCINATION SITE PAIN (Injection site was sore) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure, High cholesterol, Allergy (Adhesive tapes and band aids) and Penicillin allergy. Concomitant products included LISINOPRIL, ATORVASTATIN, EZETIMIBE (ZETIA), TOLTERODINE L-TARTRATE (DETROL LA), VITAMIN A [RETINOL] and COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced PAIN (Traveling down to the elbow), PRURITUS (Itchy), INDURATION (Felt hard), VACCINATION SITE ERYTHEMA (Injection site  red), VACCINATION SITE PAIN (Injection site was sore) and VACCINATION SITE PAIN (felt like it was burning). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PAIN (Traveling down to the elbow), PRURITUS (Itchy), INDURATION (Felt hard), VACCINATION SITE ERYTHEMA (Injection site  red), VACCINATION SITE PAIN (Injection site was sore) and VACCINATION SITE PAIN (felt like it was burning) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: Arm itches; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Arm itches) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Arm itches). At the time of the report, VACCINATION SITE PRURITUS (Arm itches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications was not provided. Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: hot; itches like crazy; one week after receiving the vaccine at the site of injection she has a huge arm rash; bright red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot), VACCINATION SITE PRURITUS (itches like crazy), INJECTION SITE RASH (one week after receiving the vaccine at the site of injection she has a huge arm rash) and VACCINATION SITE ERYTHEMA (bright red) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (hot), VACCINATION SITE PRURITUS (itches like crazy), INJECTION SITE RASH (one week after receiving the vaccine at the site of injection she has a huge arm rash) and VACCINATION SITE ERYTHEMA (bright red). At the time of the report, VACCINATION SITE WARMTH (hot), VACCINATION SITE PRURITUS (itches like crazy), INJECTION SITE RASH (one week after receiving the vaccine at the site of injection she has a huge arm rash) and VACCINATION SITE ERYTHEMA (bright red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: Patient is 25 weeks pregnant and received both doses of the Moderna vaccine; This spontaneous prospective pregnancy case was reported by a physician (subsequently medically confirmed) and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Patient is 25 weeks pregnant and received both doses of the Moderna vaccine) in a 30-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L02A and 022M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 07-Jun-2021. On 16-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Patient is 25 weeks pregnant and received both doses of the Moderna vaccine). The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. On 13-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Patient is 25 weeks pregnant and received both doses of the Moderna vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant and treatment medications were not reported.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Vaccination site erythema
Clinical narrative: Mild Nausea; arm was red from the injection site down to just above my elbow; soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (soreness), NAUSEA (Mild Nausea) and VACCINATION SITE ERYTHEMA (arm was red from the injection site down to just above my elbow) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007N20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced PAIN (soreness). On 02-Feb-2021, the patient experienced NAUSEA (Mild Nausea) and VACCINATION SITE ERYTHEMA (arm was red from the injection site down to just above my elbow). At the time of the report, PAIN (soreness), NAUSEA (Mild Nausea) and VACCINATION SITE ERYTHEMA (arm was red from the injection site down to just above my elbow) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication information was provided. No treatment information was provided by the reporter.     On 01 Feb 2021, patient got her 1st dose of the Moderna vaccine. Patient  reported soreness on the1st day. The next day on 02Feb2021, her arm was red from the injection site down to just above her elbow. Patient felt tired, and had mild nausea.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Muscle pain on the right side, in the upper chest, right underneath the breast; This spontaneous case was reported by an other health care professional and describes the occurrence of MYALGIA (Muscle pain on the right side, in the upper chest, right underneath the breast) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027L20A and 032L20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high. Concomitant products included AMLODIPINE for Blood pressure high.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Feb-2021, the patient experienced MYALGIA (Muscle pain on the right side, in the upper chest, right underneath the breast). On 07-Feb-2021, MYALGIA (Muscle pain on the right side, in the upper chest, right underneath the breast) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Bronchitis
Clinical narrative: contracted Bronchitis; This spontaneous case was reported by a consumer and describes the occurrence of BRONCHITIS (contracted Bronchitis) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced BRONCHITIS (contracted Bronchitis). At the time of the report, BRONCHITIS (contracted Bronchitis) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chills, Dizziness, Lymphadenopathy, Pain in extremity
Clinical narrative: Soreness under her left Arm; swollen lymph node; Chills; chest tightness; Dizziness; A spontaneous report was received from a healthcare professional concerning a 65-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events chest tightness/chest discomfort, dizziness, chills, soreness under her left arm/pain in extremity, swollen lymph node/lymphadenopathy.  The patient's medical history included asthma. No relevant concomitant medications were reported.  On 19 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 031L20A) via unknown route in the left arm for prophylaxis of COVID-19 infection.  On 19 Feb 2021, the patient experienced the event(s) chest tightness, dizziness, chills. On 24 Feb 2021, the patient experienced the event(s) soreness under her left arm, swollen lymph node.  Treatment details included rescue inhaler.  Action taken with mRNA-1273 in response to the events was not reported.  On 20 Feb 2021 the outcome of event(s), chest tightness, dizziness, chills was resolved. The outcome of event(s), soreness under her left arm, swollen lymph node was unknown.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: 100.2°F fever; Throw up; A spontaneous report was received from Consumer concerning a patient  50 year old, female and who received Moderna's COVID-19 vaccine(mRNA-1273) and experienced 100.2°F fever and throw up.  The patient's medical history was not provided.  Concomitant products were not provided.  On unknown date, the patient received their unknown dose of two planned doses of mRNA-1273 (Batch Number unknown) viz unknown route for prophylaxis of COVID-19 infection. The patient experienced a 100.2°F fever and the reporter said that throw up. The age of the patient is around 50.  Treatment provided was unknown.  Action taken with mRNA-1273 in response to the event was unknown.  The outcome of the event 100.2°F fever and throw up is unknown.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: tested COVID19 positive; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SARS-COV-2 TEST POSITIVE (tested COVID19 positive) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced SARS-COV-2 TEST POSITIVE (tested COVID19 positive). At the time of the report, SARS-COV-2 TEST POSITIVE (tested COVID19 positive) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Feb-2021, SARS-CoV-2 test positive: positive positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash in the arm 11 days after the vaccination; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash in the arm 11 days after the vaccination) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.    On 08-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced RASH (Rash in the arm 11 days after the vaccination). At the time of the report, RASH (Rash in the arm 11 days after the vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication were not reported by the reporter. Treatment details was not reported by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Pyrexia
Clinical narrative: diarrhea; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), PYREXIA (Fever) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhea), PYREXIA (Fever) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, DIARRHOEA (diarrhea), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication details were not reported by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: Adverse event; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Adverse event) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (Adverse event). At the time of the report, ADVERSE EVENT (Adverse event) outcome was unknown. Not Provided          Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Pain in extremity
Clinical narrative: Pain in his low leg,knee pain,hip pain; Pain on his right leg, that comes and goes up to his ankles; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain on his right leg, that comes and goes up to his ankles) and ARTHRALGIA (Pain in his low leg,knee pain,hip pain) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for COPD, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) for an unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced PAIN IN EXTREMITY (Pain on his right leg, that comes and goes up to his ankles). On an unknown date, the patient experienced ARTHRALGIA (Pain in his low leg,knee pain,hip pain). At the time of the report, PAIN IN EXTREMITY (Pain on his right leg, that comes and goes up to his ankles) and ARTHRALGIA (Pain in his low leg,knee pain,hip pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Products known to have been used by the patient, within two weeks prior to the event, included prostate medication and pain medication for the leg and hips.  Treatment for the event included ibuprofen.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Nausea, Pyrexia
Clinical narrative: Severe chills; fever of 101F; Nausea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Severe chills), PYREXIA (fever of 101F), NAUSEA (Nausea) and HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Feb-2021, the patient experienced CHILLS (Severe chills), PYREXIA (fever of 101F), NAUSEA (Nausea) and HEADACHE (Headache). At the time of the report, CHILLS (Severe chills), PYREXIA (fever of 101F), NAUSEA (Nausea) and HEADACHE (Headache) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Feb-2021, Body temperature: 101 High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reported.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Injection site pain, Myalgia
Clinical narrative: soreness/tenderness at the injection site; muscle aches; headache; chills; A spontaneous report was received from a consumer concerning a 68 years old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events soreness tenderness at the injection site /injection site pain, muscle aches /myalgia, headache, chills.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 22 Feb 2021,approximately 1 day prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 007M20A) via unknown route in the left arm for prophylaxis of COVID-19 infection.  On 22 Feb 2021, the patient experienced the event(s) soreness tenderness at the injection site, muscle aches, headache, chills.  Treatment details included Ibuprofen.  Action taken with mRNA-1273 in response to the events was not reported.   On 25 Feb 2021 the outcome of event(s), muscle aches, headache, chills was resolved. The outcome of event(s), soreness tenderness at the injection site was unknown.